Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Low Level Laser Therapy Continues to Win Support from FDA as a Hair Loss Treatment – Dr. Alan Bauman
  • USA - English


News provided by

Firm Nineteen, LLC

Jan 16, 2014, 03:00 ET

Share this article

Share toX

Share this article

Share toX


Boca Raton, Florida (PRWEB) January 16, 2014 -- For the fifth time in three years, the Food & Drug Administration (FDA) has awarded clearance to another low level laser therapy (LLLT) device for the treatment of hair loss – this time with Sunetics’ Model “G” Clinical Laser System. Nationally renowned hair loss expert Alan J. Bauman, M.D., who’s been a strong advocate of LLLT as a hair loss treatment since 1999, the most recent FDA clearance is further proof of the efficacy of low-level lasers as a hair regrowth treatment for male and female pattern hair loss.

“Once viewed with skepticism by some in the medical community, low-level laser therapy has since proven itself to be a safe and highly effective treatment for male and female pattern hair loss." Dr. Alan J. Bauman

Post this

Dr. Bauman is currently recruiting male and female hair loss patients to participate in a new laser therapy clinical trial.

“Once viewed with skepticism by some in the medical community, low-level laser therapy has since proven itself to be a safe and highly effective treatment for a wide range of health concerns, and is particularly well-suited as a treatment for male and female pattern hair loss,” Bauman said. “We’ve been incorporating LLLT into our multi-therapy regimens for the past 15 years, and I’ve seen first-hand how effective this side effect-free treatment can be for reviving dying hair follicles and stimulating hair growth in both men and women. That said, patients shouldn’t expect LLLT to regrow hair that’s dead and gone. It tends to work on weakened follicles that are still in the process of miniaturizing – so it’s critical for patients who suspect they may have hair loss to get started on this treatment as soon as possible and stick with it.”

The Sunetics Model “G” is a clinical-grade, in-office low-level laser therapy treatment armed with an array of 107 laser diodes. Unlike other hand-held or wearable laser devices, the Model “G” is a large, free-standing laser “hood” delivering powerful, continuous full coverage of the scalp in healthy laser light. Treatment sessions are 30 minutes long and patients are encouraged to undergo these treatments three times per week.

Low level laser therapy is the medical use of non-heating, low energy laser diodes to stimulate the body’s cells by increasing mitochondrial membrane potential through a process called photobiomodulation. Clinical studies have found it to have a number of medical applications - including faster wound healing, pain abatement, brain injury, lipolysis (fat loss) and stimulating regrowth in hair follicles.

Bauman was one of the first U.S. physicians to use laser therapy as an integral part of a multi-therapy approach to treat thinning hair beginning as early as 1999 and has treated thousands of patients with laser therapy since. In Puerta Vallarta in 2001, Dr. Bauman’s results from in-office laser therapy were the first laser therapy-treated patients ever presented at the International Society of Hair Restoration Surgery’s Annual Scientific Meeting. Dr. Bauman currently owns four Sunetics laser hoods located within his Laser Hair Therapy “Spa” and perioperative area of his hair transplant clinic in Boca Raton, FL. He has been a ‘beta-tester,’ medical consultant and early adopter of several low-level laser devices currently on the market. Bauman’s medical practice currently provides patients with a wide range of laser therapy options, ranging from the in-office laser “hoods” developed by Sunetics to a variety of at-home hand-held laser units and at-home wearable devices.

While Bauman is a supporter of laser therapy, he cautions consumers and patients to understand its limitations. Laser therapy is primarily effective at restarting “thinning,” or dying, hair follicles and accelerating post-op healing after a hair transplant. Laser therapy can be used in combination with other proven medical treatments like compounded minoxidil and/or finasteride, platelet-rich plasma therapy, prostaglandin analogs, nutritional supplements and NeoGraft FUE hair transplants.

About Sunetics Low Level Laser Therapy:

• Sunetics low-level laser therapy hoods help patients improve hair growth and regrow thicker, healthier hair through photobiomodulation.
• Laser therapy is a drug-free, chemical-free, side effect-free non-invasive treatment option for hair loss and hair thinning for both men and women.
• Sunetics low level laser therapy patients can expect to see hair regrowth within a few months of use but it does not reverse baldness where severe depletion of hair follicle density has already occurred.
• Recently, a number of portable laser devices have been cleared by the FDA for hair growth making at-home treatments more accessible to patients.
• Scientific Cross-sectional Hair Bundle Trichometry or HairCheck™ measurements by a certified Hair Restoration Physician should be performed before treatment and at appropriate intervals to track results.
• Improvements in hair growth from laser therapy can usually be measured in three months, with visible changes seen in six months.

Laser therapy, like other non-invasive hair growth treatments, is no ‘miracle cure,’ but it is an important tool in the treatment of damaged hair, thinning hair and hair loss. For more information on what kind of results you might achieve with laser therapy or how laser therapy can be added to your 'multi-therapy' hair restoration regimen, please contact a board-certified hair restoration physician.

For more information on Dr. Bauman’s upcoming clinical trial, visit http://www.baumanmedical.com or call 1-877-BAUMAN-9 or +1 561-394-0024.

About Dr. Alan J. Bauman

Alan J. Bauman, M.D. is a full-time hair transplant surgeon who has treated over 15,000 patients and performed over 7,000 surgical procedures since starting his hair loss practice, Bauman Medical Group, P.A. in 1997 located in Boca Raton, FL.

Dr. Bauman received his M.D. degree from New York Medical College and surgical residency training at Mt. Sinai Medical Center and Beth Israel Medical Center in New York. Dr. Bauman is one of approximately 100 physicians worldwide to achieve certification from the esteemed American and International Board of Hair Restoration Surgery. He has been an active member of the International Society of Hair Restoration Surgery as a participant and faculty member at numerous Annual Scientific Meetings and Live Surgery Workshops.

Dr. Bauman is an author of textbook chapters on the science of hair care and hair transplantation, including eyelash transplant surgery, and has been extensively featured in the world’s leading media as a medical expert and successful early-adopter of some of the most advanced technologies in the treatment of hair loss such as laser therapy and NeoGraft FUE hair transplantation.

Appearances, interviews and profiles include the Today Show, The Early Show, Good Morning America, Extra, Access Hollywood and Dateline NBC among other TV appearances. Newspaper and Magazine articles and feature stories include The New York Times, Newsweek, Cosmo, Vogue, Allure, O – The Oprah Magazine and Men’s Health among others.

Janet Shoup, Firm Nineteen, LLC, +1 (828) 424-0983, [email protected]

Modal title

Dr. Alan J. Bauman
Dr. Alan J. Bauman
At the Bauman Medical Group Laser Spa, located in Boca Raton FL, patients can relax and enjoy the lakeside view while receiving their Low Level Laser Therapy Treatments.
At the Bauman Medical Group Laser Spa, located in Boca Raton FL, patients can relax and enjoy the lakeside view while receiving their Low Level Laser Therapy Treatments.
Dr. Bauman currently owns four Sunetics laser hoods located within his Laser Hair Therapy “Spa” and perioperative area of his hair transplant clinic in Boca Raton, FL.
Dr. Bauman currently owns four Sunetics laser hoods located within his Laser Hair Therapy “Spa” and perioperative area of his hair transplant clinic in Boca Raton, FL.
An early advocate of LLLT, Dr. Bauman discussed the benefits of low level laser therapy in Milan in 2007.
An early advocate of LLLT, Dr. Bauman discussed the benefits of low level laser therapy in Milan in 2007.
Dr. Alan J. Bauman At the Bauman Medical Group Laser Spa, located in Boca Raton FL, patients can relax and enjoy the lakeside view while receiving their Low Level Laser Therapy Treatments. Dr. Bauman currently owns four Sunetics laser hoods located within his Laser Hair Therapy “Spa” and perioperative area of his hair transplant clinic in Boca Raton, FL. An early advocate of LLLT, Dr. Bauman discussed the benefits of low level laser therapy in Milan in 2007.

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.